JOYN Advisors’s CervoMed CRVO Stock Holding History

JOYN Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	-$1K	–	1773
2018 Q3	$1K	Hold	2	–	–	﹤0.01%	1579
2018 Q2	$1K	Buy	+2	New	+$1.18K	﹤0.01%	1550

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JOYN Advisors's CRVO Position: Q4 2018 in Review

JOYN Advisors sold out of CervoMed (CRVO) in Q4 2018, closing a stake of 2 shares — an estimated $1K sold.

JOYN Advisors first reported a position in CRVO in Q2 2018 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 11 funds tracked by Wall St. Rank hold CRVO as of Q4 2018.

JOYN Advisors reported no remaining CervoMed position as of Q4 2018 after selling out during the quarter.
JOYN Advisors sold 2 CervoMed shares in Q4 2018, an estimated $1K.
JOYN Advisors first reported a position in CervoMed in Q2 2018 and held it in 2 quarters.
JOYN Advisors's CervoMed position peaked at $1K in Q3 2018.
11 funds tracked by Wall St. Rank held CervoMed as of Q4 2018.

Based on JOYN Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.